摘要
癌症是一个全球性的健康问题,它损害了患者的生活质量,每年在全世界造成数千人死亡。前列腺六跨膜上皮抗原(STEAP 1)的鉴定ED在几种癌症,即前列腺癌(PCA)中过度表达。考虑到它的二级结构,以及它在细胞膜中的位置,有人建议它扮演一个角色i。肿瘤细胞间的细胞间通讯。考虑到STEAP 1在人类癌症中的高特异性和高表达,STEAP 1是目前应用于临床的一种很有前途的治疗方法。c目标。在过去的几年里,针对STEAP 1的一些策略已经被开发出来,包括抗体-药物结合物,单克隆抗体(MAb),dna疫苗和小的非编码RNAs。(NcRNA)。本文就STEAP 1蛋白在人体组织中的表达、生物化学特性及靶向策略等方面的研究进展作一综述,以评价STEAP 1蛋白在人体组织中的表达潜力癌症的治疗剂。
关键词: STEAP 1,癌症,DNA疫苗,单克隆抗体,小非编码RNA,前列腺癌。
图形摘要
Current Cancer Drug Targets
Title:Targeting STEAP1 Protein in Human Cancer: Current Trends and Future Challenges
Volume: 18 Issue: 3
关键词: STEAP 1,癌症,DNA疫苗,单克隆抗体,小非编码RNA,前列腺癌。
摘要: Cancer is a global health issue that impairs the life quality of patients and origins thousands of deaths annually worldwide. Six-transmembrane epithelial antigen of the prostate (STEAP1) was identified to be overexpressed in several types of cancers, namely in prostate cancer (PCa). Considering its secondary structure, associated with its location in the cell membrane, has been suggested a role in intercellular communication between tumour cells. Taking into account its high specificity and overexpression in human cancers, STEAP1 is nowadays a promising candidate to be imposed as a therapeutic target. Several strategies have been developed during the last few years for targeting STEAP1, including antibody-drug conjugates, monoclonal antibodies (mAbs), DNA vaccines and small noncoding RNAs (ncRNAs). This review presents the current knowledge about STEAP1 protein expression in human tissues, its biochemical properties and targeting strategies with the purpose to evaluate its potential as therapeutic agent for cancer.
Export Options
About this article
Cite this article as:
Targeting STEAP1 Protein in Human Cancer: Current Trends and Future Challenges, Current Cancer Drug Targets 2018; 18 (3) . https://dx.doi.org/10.2174/1568009617666170427103732
DOI https://dx.doi.org/10.2174/1568009617666170427103732 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
Related Books
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Aspirin: from a Historical Perspective
Recent Patents on Cardiovascular Drug Discovery Nanoparticulate Drug Delivery Sytem for Cancer Therapy: Oppourtunities and Challenges
Recent Patents on Nanomedicine The HGF-Met Signaling Axis: Emerging Themes and Targets of Inhibition
Current Protein & Peptide Science Vacuolar H+-ATPase Signaling Pathway in Cancer
Current Protein & Peptide Science Anticancer Activity and Topoisomerase II Inhibition of Naphthalimides with ω-Hydroxylalkylamine Side-Chains of Different Lengths
Medicinal Chemistry Gemcitabine Resistance is Associated with Epithelial-Mesenchymal Transition and Induction of HIF-1α in Pancreatic Cancer Cells
Current Cancer Drug Targets Progress and Prospects: The Use of 3D Spheroid Model as a Relevant Way to Study and Optimize DNA Electrotransfer
Current Gene Therapy Effect-based Hazard Identification of House Dust by In Vitro Assays Detecting Dioxin-like Compounds, Thyroid and Reproductive Toxicants
Current Organic Chemistry Ganoderma lucidum: A Source for Novel Bioactive Lectin
Protein & Peptide Letters Nanotechnology for Alzheimer Disease
Current Alzheimer Research Druggability of Mortalin for Cancer and Neuro-Degenerative Disorders
Current Pharmaceutical Design Vitamin D Analogs as Anti-Carcinogenic Agents
Anti-Cancer Agents in Medicinal Chemistry GnRH-Analogues for Ovarian Protection in Childhood Cancer Patients: How Adult Hypotheses are Relevant in Prepubertal Females
Current Drug Targets Dextran-based Nanocarriers for Delivery of Bioactives
Current Pharmaceutical Design CuAAC Click Chemistry Accelerates the Discovery of Novel Chemical Scaffolds as Promising Protein Tyrosine Phosphatases Inhibitors
Current Medicinal Chemistry The Antiprogestogen Mifepristone: A Review
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Recent Progress in the Development of Histone Deacetylase Inhibitors as Anti-Cancer Agents
Mini-Reviews in Medicinal Chemistry Amyloid β -Protein Assembly as a Therapeutic Target of Alzheimers Disease
Current Pharmaceutical Design New Bioactive Metabolites from the Marine-derived Fungi Aspergillus
Mini-Reviews in Medicinal Chemistry The Synthetic and Biological Attributes of Pyrazole Derivatives: A Review
Mini-Reviews in Medicinal Chemistry